And now spreading the dreaded CR fear on the other thread, vey Plodge-esque. Ignoring the company's (and balance sheet/4C's) very clear indication of being cashed up until mid-2026 of which there are various clinical and other results due before, which will raise the likelihood of a commercial partnership to accompany its various academic (and often trial funding) partnerships it already has in place.
They are a bore. But worse they purposefully spread misleading information on CYP for reasons known only to them.
Ann: CYP-001s FDA Approval Pathway Not Impeded, page-16
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.010(5.56%) |
Mkt cap ! $38.41M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.5¢ | $21.40K | 127.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 425750 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 90178 | 3 |
View Market Depth
| Last trade - 14.06pm 13/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |